These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Psychiatric drugs and trends: review of the phenothiazines. 1. Dembicki EL J Psychiatr Nurs Ment Health Serv; 1974; 12(3):47-8. PubMed ID: 4151849 [No Abstract] [Full Text] [Related]
24. Effect of phenothiazines on central cholinergic activity. Van Woert MH; Sethy VH; Ambani LM Adv Biochem Psychopharmacol; 1974; 9(0):707-15. PubMed ID: 4151771 [No Abstract] [Full Text] [Related]
25. Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment. Wintrob RM Dis Nerv Syst; 1970 Sep; 31():Suppl:50-62. PubMed ID: 4990944 [No Abstract] [Full Text] [Related]
26. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate]. Berliner J Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024 [No Abstract] [Full Text] [Related]
27. [Therapeutic management, the hospital environment]. Gayral L Encephale; 1970; ():Suppl:19-25. PubMed ID: 5458709 [No Abstract] [Full Text] [Related]
28. Effect of formulation of intramuscular injections of phenothiazines on duration of activity. Florence AT; Jenkins AW; Loveless AH J Pharm Sci; 1976 Nov; 65(11):1665-8. PubMed ID: 11335 [TBL] [Abstract][Full Text] [Related]
29. [Increase of sulfobromophthalein clearance by phenothiazines]. Denis P; Le Leannec AM; Benhamou JP Nouv Presse Med; 1973 Dec; 2(43):2881-3. PubMed ID: 4149342 [No Abstract] [Full Text] [Related]
30. Drug monitoring at an Australia depot phenothiazine clinic. Marriott P; Hiep A J Clin Psychiatry; 1978 Mar; 39(3):206-12. PubMed ID: 580271 [TBL] [Abstract][Full Text] [Related]
31. The myth of the magic antipsychotic. Moncrieff J Ment Health Today; 2008 Jun; ():18-9, 22. PubMed ID: 18663800 [No Abstract] [Full Text] [Related]
32. Sex differences in long-term adverse effects of phenothiazines. Lehmann HE; Ban TA Adv Biochem Psychopharmacol; 1974; 9(0):249-54. PubMed ID: 4151763 [No Abstract] [Full Text] [Related]
33. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders]. Moldenhauer B Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636 [No Abstract] [Full Text] [Related]
34. [Antipsychotic agents: from phenothiazines to atypical neuroleptics of the second generation]. Raevskiĭ KS Eksp Klin Farmakol; 2003; 66(2):6-9. PubMed ID: 12962040 [TBL] [Abstract][Full Text] [Related]
36. Shaping up the depot. Day J; Henderson B; Butterworth T Nurs Times; 1995 Nov 1-7; 91(44):51-4. PubMed ID: 7501527 [No Abstract] [Full Text] [Related]
37. The long-acting neuroleptics: a retrospective appraisal. Yale HL Drug Metab Rev; 1978; 8(2):251-62. PubMed ID: 31272 [No Abstract] [Full Text] [Related]
38. Correlations between the results of pharmacokinetic and pharmacological studies on several pipotiazine esters. Julou L; Bourat G; Ducrot R; Fournel J; Garret C; Mottet F Therapie; 1973; 28(3):475-99. PubMed ID: 4149220 [No Abstract] [Full Text] [Related]